These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16759391)

  • 1. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.
    Custer B; Longstreth WT; Phillips LE; Koepsell TD; Van Belle G
    BMC Cancer; 2006 Jun; 6():152. PubMed ID: 16759391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous hormone use and meningioma risk: what do we tell our patients?
    Claus EB; Black PM; Bondy ML; Calvocoressi L; Schildkraut JM; Wiemels JL; Wrensch M
    Cancer; 2007 Aug; 110(3):471-6. PubMed ID: 17580362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
    Korhonen K; Raitanen J; Isola J; Haapasalo H; Salminen T; Auvinen A
    Cancer Causes Control; 2010 Dec; 21(12):2149-56. PubMed ID: 20730482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and Progesterone Therapy and Meningiomas.
    Hage M; Plesa O; Lemaire I; Raffin Sanson ML
    Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34935947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma.
    Harland TA; Freeman JL; Davern M; McCracken DJ; Celano EC; Lillehei K; Olson JJ; Ormond DR
    J Neurooncol; 2018 Jan; 136(2):327-333. PubMed ID: 29081037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of meningioma with reproductive factors.
    Lee E; Grutsch J; Persky V; Glick R; Mendes J; Davis F
    Int J Cancer; 2006 Sep; 119(5):1152-7. PubMed ID: 16570277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
    Hsu DW; Efird JT; Hedley-Whyte ET
    J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and risk of meningioma in women: a meta-analysis.
    Fan ZX; Shen J; Wu YY; Yu H; Zhu Y; Zhan RY
    Cancer Causes Control; 2013 Aug; 24(8):1517-25. PubMed ID: 23702884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal therapies and meningioma: is there a link?
    Cea-Soriano L; Blenk T; Wallander MA; Rodríguez LA
    Cancer Epidemiol; 2012 Apr; 36(2):198-205. PubMed ID: 21943794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone replacement therapy and meningioma.
    Prescrire Int; 2010 Jun; 19(107):120. PubMed ID: 20738039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy increases the risk of cranial meningioma.
    Andersen L; Friis S; Hallas J; Ravn P; Schrøder HD; Gaist D
    Eur J Cancer; 2013 Oct; 49(15):3303-10. PubMed ID: 23800670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
    Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
    Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E
    Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptors in meningiomas.
    Cahill DW; Bashirelahi N; Solomon LW; Dalton T; Salcman M; Ducker TB
    J Neurosurg; 1984 May; 60(5):985-93. PubMed ID: 6716168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
    Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy and central nervous system tumors: Danish nested case-control study.
    Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
    PLoS Med; 2023 Dec; 20(12):e1004321. PubMed ID: 38113227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.